POWI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
POWI is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The recent drop has pushed the stock down, but the technical picture is still weak, proprietary trading signals are absent, insider selling is elevated, and there is no fresh news or financial quarter data to confirm a durable turnaround. Analyst sentiment is mixed but improving, with multiple target raises and several bullish notes, which supports long-term interest, but the current setup is better suited to waiting for clearer confirmation rather than buying immediately. Given the user's impatience, my direct view is: do not buy now.
Price closed at 70.875 after a sharp -9.07% regular-session move from 72.99, with post-market weakness continuing. The stock is trading below its pivot of 81.258 and only slightly above S1 at 73.508, which means price is near a nearby support zone but has not regained trend strength. MACD histogram is -1.068 and negatively expanding, showing bearish momentum. RSI_6 at 32.123 is near oversold but not a confirmed reversal signal. Moving averages are converging, which suggests a possible base-building phase, but not yet a confirmed uptrend. Overall, the chart is weak to neutral, with downside pressure still dominant.
Analyst sentiment has improved materially, with Stifel raising its target to $95 and maintaining Buy, Susquehanna raising to $85 with a Positive rating, and Benchmark keeping it as a Best Idea. Analysts are pointing to AI DC opportunity, GaN expansion, and strengthening end demand. The stock trend model also suggests modest positive follow-through over the next day, week, and month.
No news in the recent week means there is no fresh event-driven catalyst to drive immediate momentum. Insider activity is a major negative: insiders are selling, and the selling amount increased 2971.69% over the last month. Hedge funds are neutral with no significant trading trends. Technical momentum is bearish, and the recent sharp price drop shows sellers are in control right now.
No reliable latest-quarter financial snapshot was provided because the financial data returned an error, so I cannot assess revenue or earnings growth for the latest season. Based on the analyst commentary, the company appears to be executing well enough to attract higher price targets, especially around its AI DC and GaN opportunities, but the absence of actual quarter figures prevents a direct financial growth assessment.
Analyst sentiment is moderately positive and improving. Recent updates show Stifel raising its target from $82 to $95 and keeping Buy, Susquehanna raising to $85 and keeping Positive, Benchmark maintaining a Buy/Best Idea stance with a $65 target, while Deutsche Bank remains Hold with a $65 target. The pros view is that POWI is a long-term innovator with upside from AI-levered and GaN-related growth. The cons view is that some analysts still see only fair value or caution around exposure and execution, so Wall Street is constructive but not unanimous.
